It would be interesting to conduct further analysis on different types of bvFTD, stratifying patients by their genetic cause, where known, or by pathological protein hallmarks (e.g., TDP-43, TAU), and certainly by clinical presentation, and whether patients suffer from pure bvFTD or mixed forms with additional motor alterations (ALS–FTD mixed forms). The gene discussed is TARDBP; the disease is frontotemporal dementia.